DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
11,100
Employees11,100
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
11,100
Employees11,100

DXCM Key Statistics

Market cap
29.81B
Market cap29.81B
Price-Earnings ratio
31.77
Price-Earnings ratio31.77
Dividend yield
—
Dividend yield—
Average volume
4.94M
Average volume4.94M
High today
$81.07
High today$81.07
Low today
$79.18
Low today$79.18
Open price
$80.95
Open price$80.95
Volume
3.08M
Volume3.08M
52 Week high
$92.59
52 Week high$92.59
52 Week low
$55.84
52 Week low$55.84

Stock Snapshot

With a market cap of 29.81B, DexCom(DXCM) trades at $79.92. The stock has a price-to-earnings ratio of 31.77.

As of 2026-11-11, DexCom(DXCM) stock has fluctuated between $79.18 and $81.07. The current price stands at $79.92, placing the stock +0.9% above today's low and -1.4% off the high.

The DexCom(DXCM)'s current trading volume is 3.08M, compared to an average daily volume of 4.94M.

During the past year, DexCom(DXCM) stock moved between $55.84 at its lowest and $92.59 at its peak.

During the past year, DexCom(DXCM) stock moved between $55.84 at its lowest and $92.59 at its peak.

DXCM News

Simply Wall St 1d
Is DexCom Still Below Fair Value As Guidance Rises And Buybacks Begin?

DexCom (DXCM) just packed several updates into one week, pairing a third quarter earnings release and higher 2026 revenue outlook with a new share repurchase pl...

Is DexCom Still Below Fair Value As Guidance Rises And Buybacks Begin?
Simply Wall St 6d
DexCom Stock Has The Bull Case Changed After The Canada Launch And Guidance Raise

DexCom reported third quarter 2026 sales of US$1.34b with stable basic EPS from continuing operations, raised full year revenue guidance, and announced a US$1b...

DexCom Stock Has The Bull Case Changed After The Canada Launch And Guidance Raise

Analyst ratings

87%

of 31 ratings
Buy
87.1%
Hold
12.9%
Sell
0%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.